Bruker has announced significant upgrades to its MALDI Biotyper and IR Biotyper platforms at the ESCMID Global 2026 conference, marking a major leap forward in microbial identification technology. The enhancements streamline workflows for faster, more accurate pathogen detection in clinical and research settings.
The expanded portfolio now includes advanced capabilities for outbreak analysis and reflex next-generation sequencing typing, enabling laboratories to respond more effectively to infectious disease threats. These improvements address critical needs in modern microbiology, where rapid identification and characterization of microorganisms can significantly impact patient outcomes and public health responses.
With these workflow enhancements, Bruker strengthens its position as a leader in mass spectrometry-based microbial identification. The new features promise to reduce turnaround times while improving diagnostic confidence, making advanced microbial analysis more accessible to laboratories worldwide.
Source: Read original article
